Fukuoka, Japan

Hiroshi Enaida

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Kyushu University. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hiroshi Enaida. Retrieved from https://idiyas.com/inventor/hiroshi-enaida-owh3x0sr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hiroshi Enaida: Innovator in Ophthalmic Solutions

Introduction

Hiroshi Enaida is a notable inventor based in Fukuoka, Japan. He has made significant contributions to the field of ophthalmology through his innovative work. His expertise and dedication have led to the development of a unique staining composition that aids in ophthalmic procedures.

Latest Patents

Hiroshi Enaida holds a patent for a staining composition designed for staining an ophthalmic membrane during the removal process. This composition features a Brilliant Blue G (BBG) derivative as its primary component, enhancing the effectiveness of ophthalmic membrane removal.

Career Highlights

Enaida is affiliated with Kyushu University, where he continues to engage in research and development. His work has garnered attention for its practical applications in medical procedures, particularly in ophthalmology.

Collaborations

Throughout his career, Hiroshi Enaida has collaborated with esteemed colleagues, including Toshio Hisatomi and Tatsuro Ishibashi. These partnerships have contributed to the advancement of his research and the successful implementation of his inventions.

Conclusion

Hiroshi Enaida's contributions to ophthalmology through his innovative staining composition exemplify the impact of dedicated research and collaboration in the field. His work continues to influence medical practices and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…